Atlas Trials

Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.

Clinical trial NCT06705127 · RECRUITING

Trial details

NCT number
NCT06705127
Sponsor
First Affiliated Hospital of Zhejiang University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
HR-positive,HER2-negative Breast Cancer
Start date
2024-07-01
Primary completion
2025-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.